Uloric ® (febuxostat) - Increased Risk Of Cardiovascular Fatal Outcomes

ULORIC (febuxostat) Recall Summary ULORIC, a medication used to treat gout, is being recalled across Canada due to an increased risk of cardiovascular fatal outcomes. The drug has been found to carry a higher risk of heart-related deaths in patients who take it. This recall affects all ULORIC products distributed in Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2019-11-04

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b3ae6bf7-feab-46d1-859d-d5db09dec862